News

Acutaas Chemicals Ltd share price jumped 13.34% to Rs 3794.55 after the company`s net profit saw a strong growth of 64.21% to Rs 123.14 crore, while revenue from operations increased sharply by 32.53% to Rs 436.92 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, easing 4.06%. It has marginally improved by 3.17% over last one week and softened by 0.26% in last one month while the market capitalization of Acutaas Chemicals Ltd has sharply increased by 20.20% and 17.35% in the same period respectively. Profit before tax (PBT) of Acutaas Chemicals Ltd stood at Rs 167.36 crore in Q3 FY26, rallying 74.01% year-on-year, and jumping 61.06% quarter-on-quarter. EBITDA came in at Rs 171 crore, surging by 99.89% YoY and expanding by 53.56% sequentially. Total expenses surged 20.85% to Rs 273.64 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 156.49 crore, marginally falling by 5.60% YoY, while employee benefits expense was at Rs 42.06 crore, inching up 6.29% YoY. For the TTM ended FY26, revenue from operations jumped by 33.02% to Rs 1339.37 crore, while net profit soared by 122.15% to Rs 356.37 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 22351% to Rs 438.81 crore, and PBT witnessed a strong rise of 123.32% to Rs 482.73 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 292.17 crore in FY26, as against Rs 118.34 crore in FY25. Acutaas Chemicals Ltd rallied 118.90% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.

Acutaas Chemicals Ltd share price climbed 6.67% to Rs 3347.85 after the company`s net profit jumped 64.21% to Rs 123.14 crore, while revenue from operations gained significantly 32.53% to Rs 436.92 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, easing 3.34%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of Acutaas Chemicals Ltd has improved by 2.85% and 1.21% in the same period respectively. Profit before tax (PBT) of Acutaas Chemicals Ltd stood at Rs 167.36 crore in Q3 FY26, expanding by 74.01% year-on-year, and surging by 61.06% quarter-on-quarter. EBITDA came in at Rs 171 crore, jumping 99.89% YoY and rallying 53.56% sequentially. Total expenses witnessed a sharp rise of 20.85% to Rs 273.64 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 156.49 crore, slightly declining by 5.60% YoY, while employee benefits expense was at Rs 42.06 crore, ticking higher by 6.29% YoY. For the TTM ended FY26, revenue from operations soared by 33.02% to Rs 1339.37 crore, while net profit surged by 122.15% to Rs 356.37 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 22351% to Rs 438.81 crore, and PBT witnessed a strong rise of 123.32% to Rs 482.73 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 292.17 crore in FY26, as against Rs 118.34 crore in FY25. Acutaas Chemicals Ltd rallied 93.13% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.18% during the same period.

Net profit of Acutaas Chemicals rose 67.67% to Rs 74.26 crore in the quarter ended June 2026 as against Rs 44.29 crore during the previous quarter ended June 2025. Sales rose 59.08% to Rs 329.67 crore in the quarter ended June 2026 as against Rs 207.24 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales329.67207.24 59 OPM %34.3024.57 - PBDT113.7366.21 72 PBT103.9158.08 79 NP74.2644.29 68 Powered by Capital Market - Live News

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 24 July 2026.

Acutaas Chemicals announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.